Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
Identifieur interne : 006719 ( Main/Exploration ); précédent : 006718; suivant : 006720Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
Auteurs : Salvatore L. RuggieroSource :
- Clinical Cases in Mineral and Bone Metabolism [ 1724-8914 ] ; 2007.
Abstract
Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant complication in a subset of patients receiving these drugs. Based on a growing number of case reports and institutional reviews, bisphosphonate therapy may cause exposed and necrotic bone that is isolated to the jaw. This complication usually presents following simple dentoalveolar surgery and can cause a significant adverse effect on the quality of life for most patients. The pathogenesis for this complication appears to be related to the profound inhibition of osteoclast function and bone remodeling. This report will review the clinical signs and symptoms and risks associated with this new complication and provide a guideline for establishing a stage-specific diagnosis of BRONJ.
Url:
PubMed: 22460751
PubMed Central: 2781180
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 002272
- to stream Pmc, to step Curation: 002272
- to stream Pmc, to step Checkpoint: 002695
- to stream Ncbi, to step Merge: 003D16
- to stream Ncbi, to step Curation: 003D16
- to stream Ncbi, to step Checkpoint: 003D16
- to stream Main, to step Merge: 006818
- to stream Main, to step Curation: 006719
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)</title><author><name sortKey="Ruggiero, Salvatore L" sort="Ruggiero, Salvatore L" uniqKey="Ruggiero S" first="Salvatore L." last="Ruggiero">Salvatore L. Ruggiero</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">22460751</idno><idno type="pmc">2781180</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2781180</idno><idno type="RBID">PMC:2781180</idno><date when="2007">2007</date><idno type="wicri:Area/Pmc/Corpus">002272</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">002272</idno><idno type="wicri:Area/Pmc/Curation">002272</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">002272</idno><idno type="wicri:Area/Pmc/Checkpoint">002695</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">002695</idno><idno type="wicri:Area/Ncbi/Merge">003D16</idno><idno type="wicri:Area/Ncbi/Curation">003D16</idno><idno type="wicri:Area/Ncbi/Checkpoint">003D16</idno><idno type="wicri:doubleKey">1724-8914:2007:Ruggiero S:guidelines:for:the</idno><idno type="wicri:Area/Main/Merge">006818</idno><idno type="wicri:Area/Main/Curation">006719</idno><idno type="wicri:Area/Main/Exploration">006719</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)</title><author><name sortKey="Ruggiero, Salvatore L" sort="Ruggiero, Salvatore L" uniqKey="Ruggiero S" first="Salvatore L." last="Ruggiero">Salvatore L. Ruggiero</name></author></analytic><series><title level="j">Clinical Cases in Mineral and Bone Metabolism</title><idno type="ISSN">1724-8914</idno><idno type="eISSN">1971-3266</idno><imprint><date when="2007">2007</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Bisphosphonates are a class of agents used to treat osteoporosis and malignant bone metastases. Despite these benefits, osteonecrosis of the jaws has recently emerged as a significant complication in a subset of patients receiving these drugs. Based on a growing number of case reports and institutional reviews, bisphosphonate therapy may cause exposed and necrotic bone that is isolated to the jaw. This complication usually presents following simple dentoalveolar surgery and can cause a significant adverse effect on the quality of life for most patients. The pathogenesis for this complication appears to be related to the profound inhibition of osteoclast function and bone remodeling. This report will review the clinical signs and symptoms and risks associated with this new complication and provide a guideline for establishing a stage-specific diagnosis of BRONJ.</p></div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Ruggiero, Salvatore L" sort="Ruggiero, Salvatore L" uniqKey="Ruggiero S" first="Salvatore L." last="Ruggiero">Salvatore L. Ruggiero</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 006719 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 006719 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= EdenteV2
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:2781180
|texte= Guidelines for the diagnosis of bisphosphonate-related osteonecrosis of the jaw (BRONJ)
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:22460751" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a EdenteV2
| This area was generated with Dilib version V0.6.32. |  |